ASDr. Ahmed ShihabConsultant Anesthesiologist – Baghdad عربي

Management of Coexisting Disease in the Perioperative Period

Topic notes · Applied Anaesthesia · Preoperative assessment

Chronic comorbid diseases represent a daily clinical challenge that requires careful assessment and management in the operating theatre. Proper assessment aims to optimise physiological parameters and reduce the likelihood of serious complications during and after anaesthesia.

Cardiovascular disease and hypertension

In patients who have undergone coronary interventions, elective non-cardiac surgery should be delayed for 14 days after balloon angioplasty, 30 days after bare-metal stents, and 6 months after drug-eluting stents. If it becomes necessary to stop a P2Y12 inhibitor, Aspirin must be continued. Regarding hypertension, the first and second stages (Stage 1–2) are not considered an independent risk factor and surgery should proceed, whereas the third stage (Stage 3, i.e. pressure above 180/110 mmHg) accompanied by end-organ damage warrants postponing elective surgery. Changes in MAP exceeding 20% up or down from the patient's baseline should always be avoided.

Diabetes mellitus and glucose control

The perioperative target for glucose concentration should be between 6–10 mmol/L, with an acceptable maximum of 12 mmol/L, taking care to measure blood glucose at least hourly during the surgical intervention. A variable-rate IV insulin infusion is indicated when more than one meal is missed, in patients with type one diabetes not taking basal insulin, in cases of poor control, and also in emergency operations. When this infusion is used, long-acting insulin continues to be given at a dose equivalent to 80% of the usual dose.

Respiratory disease and obesity syndrome

Stopping smoking 12 hours before surgery contributes to lowering carboxyhaemoglobin, whereas reducing the risk of pulmonary complications requires abstinence for 8 weeks to normalise their rate. In patients with chronic obstructive pulmonary disease (COPD), ventilation is set with a slow inspiratory flow and a long expiratory time, with N2O avoided altogether if bullae are present. In obstructive sleep apnoea, the STOP-BANG questionnaire helps classify risk as low (0–2), intermediate (3–4), and high (5–8). For obese patients, the ramped position, which places the ear at the level of the sternum, should be used, with doses of non-depolarising muscle relaxants and opioids titrated on lean body weight, and Suxamethonium on adjusted body weight.

Considerations in chronic renal failure

When dealing with a patient with chronic kidney disease (CKD), caution should be exercised with Suxamethonium because it raises serum potassium concentration by about 0.5 mmol/L. Atracurium and Cisatracurium are safe to use because they do not depend on renal excretion. Pethidine must be strictly avoided to prevent accumulation of the neurotoxic metabolite Norpethidine, which provokes convulsions, and non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided.

Key points
  • Elective surgery is delayed 6 months after drug-eluting stents and 30 days after bare-metal stents, with Aspirin maintained if a P2Y12 inhibitor is stopped.
  • Third-stage hypertension (>180/110) with end-organ damage postpones elective surgery, and MAP fluctuation of more than 20% should be avoided.
  • The target glucose level is 6–10 mmol/L, and variable-rate IV insulin is indicated when >1 meal is missed, with 80% of the long-acting insulin given.
  • In obesity, the patient is placed in the ramped position and opioids and non-depolarising relaxants are calculated on lean body weight.
  • In chronic kidney disease (CKD), Atracurium and Cisatracurium are considered safe, and Pethidine and NSAIDs should be avoided.

Sources

  • Smith and Aitkenhead's Textbook of Anaesthesia, p. 403
  • Oxford Handbook of Anaesthesia, pp. 46–47
  • Smith and Aitkenhead's Textbook of Anaesthesia, p. 422
  • Smith and Aitkenhead's Textbook of Anaesthesia, pp. 421–422
  • Oxford Handbook of Anaesthesia, p. 546
  • Smith and Aitkenhead's Textbook of Anaesthesia, p. 406
  • Oxford Handbook of Anaesthesia, p. 98
  • Oxford Handbook of Anaesthesia, p. 49
  • Oxford Handbook of Anaesthesia, pp. 122–124

Test yourself: 6 questions on this topic and many more →

Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.